Allspring Global Investments Holdings, LLC Immuno Gen, Inc. Transaction History

Allspring Global Investments Holdings, LLC

$62.1 Billion
Q3 2024

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 27, 2023	BUY	$14.09 - $19.87 $182,141 - $256,859	12,927 New	12,927 $205,000
Q2 2023 Jul 18, 2023	BUY	$3.75 - $20.05 $16,455 - $87,979	4,388 Added 144.63%	7,422 $140,000
Q1 2023 Apr 13, 2023	SELL	$3.67 - $4.92 $29,492 - $39,537	-8,036 Reduced 72.59%	3,034 $11,000
Q4 2022 Jan 23, 2023	SELL	$4.55 - $6.31 $1,101 - $1,527	-242 Reduced 2.14%	11,070 $0
Q3 2022 Oct 26, 2022	SELL	$4.48 - $6.47 $32,372 - $46,752	-7,226 Reduced 38.98%	11,312 $54,000
Q2 2022 Jul 25, 2022	SELL	$3.15 - $5.76 $544,502 - $995,662	-172,858 Reduced 90.31%	18,538 $83,000
Q1 2022 May 02, 2022	SELL	$4.26 - $7.48 $15,238 - $26,755	-3,577 Reduced 1.83%	191,396 $911,000
Q4 2021 Jan 28, 2022	BUY	$4.75 - $7.5 $926,121 - $1.46 Million	194,973 New	194,973 $1.45 Million

Others Institutions Holding IMGN

# of Institutions

Shares Held

1.41M

Call Options Held

Put Options Held

View Full List

About ImmunoGen, Inc.

Ticker IMGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 220,712,992
Description
ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sun...

More about IMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Allspring Global Investments Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Allspring Global Investments Holdings, LLC with notifications on news.

Account